GBP2
(Guanylate Binding Protein 2, Interferon-Inducible (GBP2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-GBP2 antibody (Catalog #: ARP54714_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
GBP2
(Guanylate Binding Protein 2, Interferon-Inducible (GBP2))
Synonyme
guanylate binding protein 2 Peptide, guanylate binding protein 2, interferon-inducible Peptide, GTP binding protein 2 L homeolog Peptide, GBP2 Peptide, Gbp2 Peptide, gtpbp2.L Peptide
Hintergrund
GBPs are characterized by their ability to specifically bind guanine nucleotides (GMP, GDP, and GTP). GBP2 is a GTPase that converts GTP to GDP and GMP. Interferons are cytokines that have antiviral effects and inhibit tumor cell proliferation. They induce a large number of genes in their target cells, including those coding for the guanylate-binding proteins (GBPs). GBPs are characterized by their ability to specifically bind guanine nucleotides (GMP, GDP, and GTP). The protein encoded by this gene is a GTPase that converts GTP to GDP and GMP.
Alias Symbols: -
Protein Interaction Partner: BTBD2,FXR1,HSPE1,KLHL20,LSM2,MAGI1,PAFAH1B3,PPP1R8,SAT1,SEPHS1,SERPINB9,TFG,BTBD2,FXR1,HSPE1,KLHL20,LSM2,PAFAH1B3,PPP1R8,SAT1,SEPHS1,SERPINB9,TFG